<DOC>
	<DOCNO>NCT01907048</DOCNO>
	<brief_summary>This cross-sectional epidemiologic study measure physician patient awareness understand key message Xarelto prescriber guide Xarelto patient alert card .</brief_summary>
	<brief_title>Patient Physician Knowledge Key Safety Messages</brief_title>
	<detailed_description />
	<mesh_term>Rivaroxaban</mesh_term>
	<criteria>Inclusion criterion : Prescription rivaroxaban past 6 month adult patient Prevention stroke systemic embolism nonvalvular atrial fibrillation ( SPAF ) Treatment deep venous thrombosis ( DVT ) prevention recurrent DVT pulmonary embolism ( PE ) follow acute DVT . Patient eligibility : Use rivaroxaban SPAF DVT within previous 3 month ; age 18 year ; able understand complete consent form patient questionnaire .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Survey</keyword>
	<keyword>Effectiveness risk minimization measure</keyword>
	<keyword>Rivaroxaban</keyword>
	<keyword>Anticoagulants</keyword>
</DOC>